Item 1.01 Entry into a Material Definitive Agreement.





Correction to Form 8-K

On May 27, 2021, Agentix Corp., a Nevada corporation (the "Company"), filed a Current Report on Form 8-K (the "May 27, 2021 Form 8-K") disclosing, among other things, that in connection with that certain License Agreement (the "License Agreement"), dated May 10, 2021, by and between Applied BioPharma LLC, a Nevada limited liability company ("Applied BioPharma"), and National Health Research Institutes, a Taiwan, Republic of China, entity, that Applied BioPharma was a wholly-owned subsidiary of the Company. The Company hereby corrects the May 27, 2021 Form 8-K to clarify that Applied BioPharma was not a wholly-owned subsidiary at the time of filing of the May 27, 2021 Form 8-K.

Agreement and Plan of Merger

On July 13, 2021, the Company entered into an Agreement and Plan of Merger (the "Merger Agreement"), by and among the Company, AB Merger LLC, a Nevada limited liability company and wholly-owned subsidiary of the Company ("AB Merger"), and Applied Biopharma, pursuant to which Applied BioPharma is obligated to merge into AB Merger and the effect of which is that, upon and assuming consummation of the Merger Agreement, Applied Biopharma will become a wholly-owned subsidiary of the Company. The Company is obligated to pay consideration of one share of common stock for the acquisition of Applied Biopharma under the terms and conditions of the Merger Agreement.

On July 14, 2021, all parties to the Merger Agreement executed Articles of Merger to file with the Secretary of State of the State of Nevada to consummate the transactions under the Merger Agreement. On July 14, 2021, the Company arranged for Articles of Merger to be filed with Secretary of State of the State of Nevada, and expects the Articles of Merger to be filed on or about July 15, 2021.

The purpose of entering into the Merger Agreement is to make Applied BioPharma a wholly-owned subsidiary of the Company.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits:



Exhibit   Description
  2.1       Agreement and Plan of Merger (the "Merger Agreement"), dated July 13,
          2021, by and among Agentix Corp., AB Merger LLC, a Nevada limited
          liability company, and Applied Biopharma LLC, a Nevada limited liability
          company.





2

© Edgar Online, source Glimpses